Creon 180000 [USP'U]/1

Creon 180000 [USP'U]/1 is a delayed-release pancreatic enzyme supplement designed to aid digestion. It contains pancrelipase, which helps break down fats, proteins, and carbohydrates. This medication is commonly used for individuals with exocrine pancreatic insufficiency.

Creon 180000 [USP'U]/1 is primarily used to manage digestive issues related to exocrine pancreatic insufficiency. This condition occurs when the pancreas does not produce enough digestive enzymes. The medication helps the body digest fats, proteins, and carbohydrates more effectively. People with chronic pancreatitis, cystic fibrosis, or other conditions affecting the pancreas may benefit from this supplement.

Common effects of Creon 180000 [USP'U]/1 may include improved digestion and reduced symptoms such as bloating, gas, and diarrhea. Some users might experience mild stomach discomfort or changes in bowel movements. It is important to follow the advice of a healthcare provider when using this medication.

Creon 180000 [USP'U]/1 should be taken with meals or snacks to ensure proper digestion. It is important to swallow the capsules whole and not to chew or crush them. Individuals with known allergies to pork proteins or any components of the medication should avoid using it. Always consult a healthcare provider before starting any new medication.

Creon 180000 [USP'U]/1 may interact with certain medications, including antacids and other digestive aids. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the effectiveness of the medication.